Mohanty P K, Sowers J R, McNamara C, Welch B, Beck F, Thames M D
Am J Cardiol. 1985 Dec 6;56(16):28H-33H. doi: 10.1016/0002-9149(85)90540-5.
Mean arterial blood pressure, forearm vascular resistance, plasma norepinephrine, plasma renin activity and aldosterone responses to graded lower body negative pressure and tilt at 80 degrees were examined in 10 men with mild to moderate essential hypertension before and after 12 weeks of diltiazem (240 to 360 mg/day) therapy. Diltiazem therapy lowered basal supine systolic and diastolic blood pressures without affecting basal heart rate. Mean arterial blood pressure and forearm vascular resistance were decreased from 114 +/- 1.5 to 105 +/- 1 mm Hg, p less than 0.01 and from 29.3 +/- 3.5 to 18.9 +/- 2.1 units, p less than 0.01, respectively. Diltiazem therapy had no effect on basal supine levels of norepinephrine, plasma renin activity or aldosterone, nor on the responses of these hormones to lower body negative pressure. Diltiazem did decrease the forearm vascular resistance responses to lower body negative pressure and tilt. Diltiazem abolished an orthostatic increase (10 +/- 0.3 mm Hg) in mean arterial blood pressure and this was associated with a greater plasma norepinephrine response to tilt. These results suggest that diltiazem decreases vascular resistance through a reduction in the postjunctional effects of norepinephrine on vascular smooth muscle.
对10名轻度至中度原发性高血压男性患者,在接受地尔硫䓬(240至360毫克/天)治疗12周前后,检测了平均动脉血压、前臂血管阻力、血浆去甲肾上腺素、血浆肾素活性以及对分级下肢负压和80度倾斜的醛固酮反应。地尔硫䓬治疗降低了基础仰卧位收缩压和舒张压,而不影响基础心率。平均动脉血压和前臂血管阻力分别从114±1.5毫米汞柱降至105±1毫米汞柱,p<0.01,以及从29.3±3.5单位降至18.9±2.1单位,p<0.01。地尔硫䓬治疗对基础仰卧位去甲肾上腺素、血浆肾素活性或醛固酮水平无影响,对这些激素对下肢负压的反应也无影响。地尔硫䓬确实降低了前臂血管阻力对下肢负压和倾斜的反应。地尔硫䓬消除了平均动脉血压的直立性升高(10±0.3毫米汞柱),这与血浆去甲肾上腺素对倾斜的更大反应有关。这些结果表明,地尔硫䓬通过降低去甲肾上腺素对血管平滑肌的节后效应来降低血管阻力。